APLLY NOW! JR Post at AIIMS Nagpur, Check How to Complete Application Process Here…

Nagpur: The All India Institute of Medical Sciences, (AIIMS Nagpur) has invited online application for Junior Resident (Non Academic) Post on a temporary basis.

AIIMS Nagpur, established under PMSSY with the objectives of improving regional imbalances in the availability of affordable/ reliable tertiary healthcare services and also augmenting facilities for quality medical education in the country. The Institute has started functioning from session 2018-19. It is envisioned to develop into an institute with the highest standards of teaching, training, and research.

AIIMS Nagpur Vacancy Details:

Total No. of Vacancies- 50

The last date for submission online application is 9th JULY 2025.

For more details about Qualification, Age, and Pay Allowance, and much more, click on the given link:
https://medicaljob.in/jobs.php?post_type=&job_tags=aiims+nagpur&location=&job_sector=all

How to Apply for eligible candidates?

1. The aspiring applicants satisfying the eligibility criteria in all respect must submit their application through Google form link https://forms.gle/up5VL1Kpnp5MnrvK6 by 09.07.2025 05.00 P.M.

2. The applicants have to report at AIIMS Nagpur on date of written test/interview at 09:00 AM along-with the duly filled in Application form given below at Annexure-I and one set of photo copy of documents along with two passport size photos.

3. The Original certificates as detailed in the section XII of this notification– „Documents to be produced? will be verified before written test/interview. After satisfactory screening of the documents as per the Notification.

DOCUMENTS TO BE PRODUCED:

The Candidate should bring the following original documents along with the duly filled in application form (given as Annexure I) and one set of self-attested photocopies at the time of interview at the Institute (to be arranged in the following order):

1. Identity Proof (PAN Card, Passport, Driving Licence, Voter Card, Aadhar Card etc.,)

2. Address Proof (Passport, Driving License, Voter Card, Aadhar Card etc.,)

3. Certificate showing Date of Birth (10th Certificate/Birth Certificate).

4. Two recent passport size photographs.

5. Class SSC/10th&12th Certificates.

6. MBBS Mark Sheets & Certificates.

7. Internship Completion Certificate.

8. FMGE Certificate conducted by NBE (For Foreign Graduate).

9. Registration with MCI/State Medical Council.

10. Experience Certificate (copy of completion of Internship)

11. Reservation category Certificate (OBC*/SC/ST/PH) (*Candidate should belong to non-creamy layer of Central List of OBC).

12. Copy of NEFT Details in original.

13. Candidates working in Govt. / Semi-Govt., PSU should apply through proper channel only. The in services candidates will not be permitted for Interview, without “No Objection Certificate” from the employer.

14. The Orthopaedic Physical Handicapped (OPH) certificate should be issued by a duly constituted Medical Board of the State or Central Government Hospitals/Instructions.

15. All candidates, who want to avail benefit of reservation/ age relaxation / exemption offee, should enclose a copy of certificate issued by competent authority in support of their claim for reservation- exemption of fee and relaxation of age.

Also Read:AIIMS PATNA JOBS 2025: Apply For JR Post Vacancies, Check Last Date Here

Powered by WPeMatico

Safety first: Aurobindo recalls discolored pain relieving drug in US

U.S.: In a swift move to protect consumers, Aurobindo Pharma‘s U.S. unit is recalling more than 4,600 bottles of its pain reliever, Acetaminophen Tablets (325 mg), in the US market due to manufacturing issues.

As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), the US unit is recalling 4,608 bottles of the said drug due to cGMP (Current Good Manufacturing Practices) deviations.

The medication is used to relieve headaches, migraine, toothache, back pain and muscle pain, among others.

The affected lot is being recalled “due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets)”, PTI reported.

Princeton-based Aurobindo Pharma USA Inc initiated the Class II recall on May 22 this year.
As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.
Last year, Aurobindo Pharma USA recalled over 1 lakh bottles of Cinacalcet tablets in multiple strengths due to “GMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit.

Aurobindo Pharma Limited, is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. The company has 30+ manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The Company’s product portfolio is spread over seven major therapeutic/product areas encompassing CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and AntiAllergic, supported by a strong R&D set-up.

Read also: Aurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in Netherlands

Powered by WPeMatico

Medical Bulletin 28/Jun/2025

Here are the top medical news for the day:

Eating More Broccoli and Spinach May Cut Long-Term Cardiovascular Risk

A cup and a half of leafy green vegetables could go a long way to addressing atherosclerotic vascular diseases (ASVD’s), new research from Edith Cowan University (ECU), the University of Western Australia and the Danish Cancer Institute has found.

Atherosclerotic vascular diseases are a subgroup of cardiovascular disease, which are current leading causes of death world-wide, primarily due to heart attacks and strokes.

In a study of 1,436 older women (average age 75), researchers found that higher dietary vitamin K1 intake may be linked to better heart health. Using food questionnaires from 1998, they assessed vitamin K1 levels and later measured artery thickness (a sign of early atherosclerosis) in over 1,000 participants. Over 14.5 years, hospital records were analyzed, showing that women with higher vitamin K1 intake had fewer atherosclerotic vascular events.

Research led by Ms Dupuy has found that the higher dietary intake of Vitamin K1 could reduce the risk of atherosclerotic vascular diseases.

“Leafy green and cruciferous vegetables, like spinach, kale and broccoli, contain Vitamin K1 which may assist in preventing vascular calcification processes that characterise cardiovascular disease. The great news is that these vegetables can be easily incorporated into your daily meals” she said.

In addition to its’ potential role in vascular calcification inhibition, Vitamin K may also be beneficial for musculoskeletal health, through its impact on bone strength.

ECU Senior Research Fellow Dr Marc Sim noted that a cup and a half of such vegetables is an easy way to increase our daily vitamin K intake and may lower our risk for cardiovascular disease”.

“This research found women who consumed approximately 30% higher intakes of Vitamin K1 than currently recommended in the Australian Dietary Guidelines had lower long-term risk of ASVD,” he said.

“Of importance, when we examined the blood vessels in the neck, those with a higher Vitamin K1 intake also had less thickening of these blood vessels, a marker of atherosclerosis.”

Reference: Dupuy, M., Zhong, L., Radavelli-Bagatini, S. et al. Higher vitamin K1 intakes are associated with lower subclinical atherosclerosis and lower risk for atherosclerotic vascular disease-related outcomes in older women. Eur J Nutr 64, 171 (2025). https://doi.org/10.1007/s00394-025-03686-x

Can a Vegan Diet Boost Weight Loss More Than the Mediterranean Diet?

A low-fat vegan diet significantly lowers dietary acid load and supports weight loss more effectively than a Mediterranean diet, according to a new randomized crossover trial published in Frontiers in Nutrition.

“Eating acid-producing foods like meat, eggs, and dairy can increase the dietary acid load, or the amount of acids consumed, causing inflammation linked to weight gain,” says Hana Kahleova, MD, PhD, director of clinical research at the Physicians Committee and lead author of the study. “But replacing animal products with plant-based foods like leafy greens, berries, and legumes can help promote weight loss and create a healthy gut microbiome.”

The trial included 62 overweight adults who were randomly assigned to follow either a Mediterranean diet or a low-fat vegan diet for 16 weeks. After a four-week washout period, participants switched to the alternate diet for another 16 weeks. Researchers tracked participants’ dietary intake and calculated dietary acid load using two widely accepted indicators Potential Renal Acid Load (PRAL) and Net Endogenous Acid Production (NEAP). Higher scores reflect a higher acid load, which is linked to inflammation and metabolic disorders.

The results revealed that PRAL and NEAP scores decreased significantly on the vegan diet but remained unchanged on the Mediterranean diet. This reduction in acid load was directly associated with weight loss, independent of changes in calorie intake. Participants lost an average of 13.2 pounds on the vegan diet, while no significant weight change occurred on the Mediterranean diet.

Animal-based foods like meat, fish, eggs, and cheese increase acid production in the body, contributing to chronic inflammation and disrupted metabolism. In contrast, plant-based diets are more alkaline, and have been linked to improved insulin sensitivity, lower blood pressure, and weight reduction.

The researchers suggest that the alkalizing effect of a vegan diet, which raises the body’s pH and reduces acidity, could be a key mechanism behind its metabolic benefits.

Reference: Kahleova H, Maracine C, Himmelfarb J, Jayaraman A, Znayenko-Miller T, Holubkov R and Barnard ND (2025) Dietary acid load on the Mediterranean and a vegan diet: a secondary analysis of a randomized, cross-over trial. Front. Nutr. 12:1634215. doi: 10.3389/fnut.2025.1634215

Overemphasis on Weight Loss May Harm Patients: BMJ Study Finds

Focusing too heavily on weight loss for individuals with a high body mass index (BMI) may do more harm than good, according to experts writing in The BMJ. Dr. Juan Franco and colleagues argue that traditional lifestyle interventions based on calorie restriction and increased physical activity are often ineffective in the long term and may unintentionally reinforce weight stigma, leading to negative health outcomes.

The review highlights that, on average, individuals with higher body weight are unlikely to sustain meaningful weight loss over time through lifestyle changes alone. Moreover, evidence shows these interventions have little impact on reducing cardiovascular events or improving survival.

“Doctors should be prepared to inform individuals seeking weight loss about the potential benefits and harms of interventions and minimise the risk of developing eating disorders and long term impacts on metabolism,” the authors write. They stress that while healthy habits are beneficial, weight alone does not accurately reflect a person’s overall health.

The article also warns that focusing on weight can worsen societal weight bias, affecting mental health and promoting disordered eating. Instead, the authors support more holistic, patient-centered approaches like Health at Every Size (HAES), which emphasizes health and well-being without focusing on weight loss.

They conclude that quality care should be tailored to individual needs, regardless of weight. “The main goal is to offer good care irrespective of weight, which means not caring less but rather discussing benefits, harms, and what is important to the patient.”

Reference: Franco J V A, Grundtvig Gram E , Meyer L, Grandi D, Cruzat B, Christiansen L B et al. Beyond body mass index: rethinking doctors’ advice for weight loss BMJ 2025; 389 :e084654 doi:10.1136/bmj-2025-084654

Powered by WPeMatico

MP DME Releases NEET MDS 2025 Round 1 Counselling Schedule, Register NOW

Madhya Pradesh- The Madhya Pradesh Director of Medical Education (MPDME) has released the MP state National Eligibility and Entrance Test-Master of Dental Surgery (NEET MDS) 1st round Counselling tentative schedule for admission into the MDS Courses for the academic year 2025.

As per the schedule, the MP state NEET MDS 1st round 2025 Counselling will commence from today and will end on 13th July 2025. On this, the registration by the eligible candidates of the NEET MDS 2025 will start from today, i.e. 28th June 2025. Following this, the vacancies will be published on 30th June 2025 and objections against the vacancies will be invited from 01st July 2025.

Also Read: 1307 candidates allotted: MP Medical Council FMG Internship counselling Allotment List OUT

After this, the disposal of the objection will be doneon  02nd July 2025, followed by the publication of the final vacancies on the same day. Meanwhile, the merit list of the registered candidates will be published by 04th July 2025. Below is the complete schedule-

SCHEDULE

S.NO

ACTIVITY

DATE

NO. OF DAYS

1

Registration by eligible candidates of NEET MDS 2025.

28 June 2025 to 03 July 2025 (12:00 Midnight)

6 Days

2

Publication of Vacancies.

30 June 2025

1 Day

3

Invitation of Objection Against Vacancies.

01 July 2025

1 Day

4

Disposal of Objection.

02 July 2025

1 Day

5

Publication of Final Vacancies.

02 July 2025

1 Day

6

Publication of Merit list of registered candidates.

04 July 2025

1 Day

7

Choice filling and choice locking for first round.

04- 06 July 2025 (12:00 Midnight)

3 Days

8

First Round Allotment Result.

08 July 2025

5 Days

9

Reporting at the allotted college in person for document verification and admission.

09 to 13 July 2025 (06:00 PM)

5 Days

10

Online Resignation/Cancellation of admission at the college level.

09 to 13 July 2025 (07:00 PM)

5 Days

11

Exercising the option for upgradation for the second round by candidates at the time of admission*.

09 to 13 July 2025 (12:00 Midnight)

5 Days

To view the schedule, click the link below

https://medicaldialogues.in/pdf_upload/mpdme-releases-neet-mds-2025-round-1-counselling-schedule-registration-now-292638.pdf

USER MANUAL FOR PROFILE CREATION AND REGISTRATION PROCESS OF MP STATE NEET MDS COUNSELLING (MDS COURSE) (2025)

STEP 1- Please click on Create Profile.

STEP 2- To create a profile, candidates will need their NEET roll number, application number, and first (primary)mobile number registered for NEET MDS 2025 exam. An OTP will be sent only to the primary registered mobile number. Once the OTP is entered, the candidate will be able to create a personal profile.

STEP 3- Candidate’s details fetched from NEET MDS result data will be displayed on the screen. Please enter your Contact details and Bank Account details and click on “Proceed”.

STEP 4- Enter OTP received on your mobile number/email ID and create a new password. Then click on the “Validate and Save” button.

STEP 5- After clicking on the “Validate & Save” button, your profile for registration will be created and a message.

STEP 6- Candidate’s Status Tracker will show Candidate Profile turned Green and your profile has been created. Now, click on “Registration Form”.

STEP 7- The registration form will be opened. Please fill in your required details (As per your eligibility) like: – NRI Details, MBBS/BDS Completion Details, NMC/DCI registration Details, Domicile Details, Category Details, Person with Disability Details if applicable, in the registration form.

STEP 8- Please upload all documents. After that, click on the Save Enclosures button.

STEP 9- After clicking on the “Save Enclosures” button, the information submitted by the candidate will be displayed on the screen. If the information is correct, click on the “Proceed to Payment for Registration” button; otherwise, go for the “Back to Registration Form” button to correct the details.

STEP 10- Kindly choose the online payment gateway and pay the registration fee.

STEP 11- After successful payment, the registration receipt will be generated. You may take a printout of the same for future reference.

ADVISORY FOR CANDIDATES

1 The online counseling process for admission to all State Quota seats (MDS) available in government and private dental colleges of the state, which also includes NRI seats and seats for in-service candidates available in private dental colleges, will be done through Madhya Pradesh State Level Joint Counseling NEET MDS 2025 and under the Madhya Pradesh Medical Education Admission Rules 2018 and amendments issued from time to time.

2 All the eligible candidates of NEET MDS 2025 who wish to participate in the above counselling are advised not to share their login ID and password and other related information with any other person after registration, so that it is not misused.

3 Registration and online counselling process will be conducted on the designated portal of MP Online, dme.mponline.gov.in.

4 During the counselling process, all OTP and email messages will be received by the candidate on the primary mobile number (First Registered Mobile Number) and email ID registered in the NEET MDS exam database.

5 Before profile creation and registration, read and understand the Profile and Registration User Manual displayed on the Directorate’s website and portal. In case of any doubt, send your problem to the Directorate of Medical Education’s email and get it resolved. As per the rules, after the prescribed period for registration, the candidate will not be able to make any changes to the registration details.

6 Account Number, IFSC Code and Bank Name as entered at the time of profile creation (Bank Name), Branch Name and Account Holder Name, Mobile Number etc. should be the same with which the candidate wants the refund after counselling. (If applicable).

7 A candidate will be considered registered only when he has deposited the online fee of Rs 1100 for registration. The registration fee is non-refundable. It is mandatory for the candidate to have a registration slip generated from the MP Online portal, which will be received only after the fee is deposited.

8 The registration process will be done before the first phase of counselling and re-registration will be opened before the mop-up phase, in which only those eligible candidates who could not register for any reason will be able to register for the mop-up phase. Candidates already registered do not have to register again. Except the candidates admitted in the first phase, such candidates who, due to any reason, wish to make changes in their registration done before the first phase of counselling, will be given a final opportunity to make necessary changes in their registration within the prescribed time limit before the second phase of counselling. No further opportunity will be given to the candidates after the expiry of the prescribed time limit.

9 The registration process will be done as per the announced timetable. The facility of editing will be available till the last date of registration. The time allotted for registration will not be extended for any reason, such as network failure, computer failure, technical error, power outage, etc. Therefore, candidates are advised to complete the registration process within the time limit and not wait till the last date of registration.

10 In all the stages of counselling, under the counselling programme, candidates will have to register their options (choice filling) on ​​the portal within the specified time limit and it will be mandatory to lock the choice. Candidates will be able to edit their choices till the stipulated time of choice filling/locking. It will be mandatory to lock the edited choice otherwise, the choice filling locked before editing will be considered valid for allotment. Before locking the choice, the candidate will have to deposit the portal fee of Rs 100 online.

11 The process of all the stages of counselling is to be done online, hence the advance amount to be deposited by the candidate at the time of registration, before filling new choice in the second stage and mop up stage counselling and the prescribed fee of the institute at the time of admission has to be paid through online mode. The candidate can pay the fee through the online mode. The candidate can pay the prescribed fee from one account or from more than one account through net banking, credit card, debit card and online RTGS/NEFT. The candidate can use more than one net banking account, debit card or credit card for payment of the fee. Keeping the above in mind, candidates are advised to keep a sufficient amount in their accounts as per the prescribed fee of the institution to avoid the hassle of fee payment. Candidates should ensure that the internet banking facility is available in their bank account, hence increase the limit of transaction amount as per the requirement. After the mop-up phase, at the time of admission at the institution level in the stray vacancy phase, the prescribed fee of the institution can be paid by the candidate in the account of the admitted institution through any medium other than cash.

12 In the first stage of counselling, only the candidates who are local residents of Madhya Pradesh or the candidates who have passed the BDS course from any DCI-recognised dental college of Madhya Pradesh will be eligible for choice filling and choice locking.

13 After the first phase, in the counselling of subsequent phases, candidates from outside the state will also be able to do choice filling for allotment, but these candidates will be allotted only if there are no candidates available in the merit list of domicile candidates of the state.

14 Unreserved category candidates who are eligible for the EWS category will have to give the option of category as EWS while registering before counselling. The candidate must have an EWS certificate issued by the authorised officer of Madhya Pradesh, which will have to be uploaded at the time of online registration.

15 Before entering their options, candidates are advised to note down the list of their choice of colleges/subjects in advance so that they do not face any confusion during choice filling on the portal.

16 Candidates are expected to select colleges/subjects for allotment after careful consideration and keeping in mind the fees displayed on the portal and directorate of various dental colleges and given less time to choose colleges/subjects. Therefore, candidates should not fill such choices at the time of choice filling on which they are unable to take admission in case of allotment.

17 After the allotment result is declared, the candidate can download the allotment letter from his/her login ID and take its print out.

18 Online admission slip will be issued to the candidate only when he selects one of the options Yes or No for the second phase of upgradation at the time of admission at college level. Facility to edit this option will be available on the candidate’s login. This edit facility will be available only till the time period fixed for upgradation in the time table.

19 If a candidate admitted in the first phase wants the option of upgradation in the mop up phase, then it will be mandatory for him/her to do choice filling in the second phase by giving the option of upgrade after the first phase for the second phase also.

20 The allotted candidate should personally appear at the allotted institute for verification of records with the original documents mentioned in Proforma-1 at the time of admission. The allotted candidate should personally appear at the allotted institute for admission within the declared time limit (counselling time table) and first report at the desk of the Government Nodal Officer and register his/her presence online. Thereafter, get his/her original documents verified by the appointed Admission Committee of the allotted institute. The list of original documents is mentioned in Schedule-3 attached with Proforma-1/Madhya Pradesh Medical Education Admission Rules 2018. Only those candidates who are found eligible after verification will be able to get admission on the allotted seat. The candidate will have to submit all his/her original documents to the Admission Committee. The institution will have to obtain a certificate of submission of original documents from the head of the institute. Make sure to obtain a certificate signed by the Dean / Principal of the university.

21 During counseling, such candidates who will give option for upgradation for second phase/mop up phase, will not have to submit Gramin Seva Bond and Seat Living Bond at the time of admission in first phase/second phase. But they will have to edit a notarized affidavit on non-judicial stamp paper of Rs. 500/- in the name of the head of the institution to the effect that in case of not getting upgraded, Gramin Seva Bond and Seat Living Bond will be submitted as per the format.

To view the advisory, click the link below

https://medicaldialogues.in/pdf_upload/advisory-292637.pdf

Powered by WPeMatico

Brands want us to trust them. But as the SPF debacle shows, they need to earn it

It’s quite unsettling to discover something so central to our cultural rituals—the “slop” in the Aussie mantra of “Slip! Slop! Slap!”—can no longer be trusted.

Powered by WPeMatico

How early 20th century closures of US medical schools resulted in drops in mortality

Efforts in the early 20th century to improve the quality of medical education in the United States led to a steep decline in the number of medical schools and medical school graduates. In a new study, researchers examined the consequences of these medical school closures between 1900 and 1930 for the number of county-level physicians, nurses, and midwives, and for infant, non-infant, and total mortality. The closures led to a 4% reduction in physicians per capita and resulted in declines in infant mortality, non-infant mortality, and total mortality, they found.

Powered by WPeMatico

Study points to promising chemoimmunotherapy strategy for aggressive stage III non-small cell lung cancer

A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery for patients with aggressive stage III non-small cell lung cancer that is considered difficult or impossible to surgically remove can help shrink tumors and make surgery possible.

Powered by WPeMatico

Evidence lacking for new neurosteroid drugs in treating postnatal depression

Antidepressants are widely used as a drug based intervention to treat more severe cases of postnatal depression. While they are regularly prescribed, they can provide a limited response. The drugs modulate the gamma-aminobutyric acid (GABA) system—which has a key role in regulating brain activity—and have been proposed as an effective alternative to antidepressants.

Powered by WPeMatico

Urine-based tumor DNA test may help personalize bladder cancer treatment

In a multi-institutional study published in the European Urology journal, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment.

Powered by WPeMatico

Zoonotic spillover or lab leak? WHO Scientific advisory group issues report on origins of COVID 19

Geneva: The WHO Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a panel of 27 independent, international, multidisciplinary experts, today published its report on the origins of SARS-CoV-2, the virus responsible for the COVID 19 pandemic.

SAGO has advanced the understanding of the origins of COVID-19, but as they say in their report, much of the information needed to evaluate fully all hypotheses has not been provided.

“I thank each of the 27 members of SAGO for dedicating their time and expertise to this very important scientific undertaking over more than three years,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “As things stand, all hypotheses must remain on the table, including zoonotic spillover and lab leak. We continue to appeal to China and any other country that has information about the origins of COVID-19 to share that information openly, in the interests of protecting the world from future pandemics.”

Also Read:Ensure oxygen, ventilators- Centre instructs States as COVID-19 cases rise

In its report, SAGO considered available evidence for the main hypotheses for the origins of COVID-19 and concluded that “the weight of available evidence…suggests zoonotic spillover…either directly from bats or through an intermediate host.”

WHO requested that China share hundreds of genetic sequences from individuals with COVID-19 early in the pandemic, more detailed information about the animals sold at markets in Wuhan, and information on work done and biosafety conditions at laboratories in Wuhan. To date, China has not shared this information either with SAGO or WHO.

SAGO published its initial findings and recommendations in a report on 9 June 2022. Today’s report updates that evaluation based on peer-reviewed papers and reviews, as well as available unpublished information and field studies, interviews, and other reports including audit findings, government reports and intelligence reports. SAGO convened in various formats 52 times, conducted briefings with researchers, academics, journalists, and others.

“As the report says, this is not solely a scientific endeavour, it is a moral and ethical imperative,” said Dr Marietjie Venter, Chair of the group and Distinguished Professor and One Health Research Chair in Vaccines and Surveillance for Emerging viral threats at the University of the Witwatersrand, South Africa. “Understanding the origins of SARS-CoV-2 and how it sparked a pandemic is needed to help prevent future pandemics, save lives and livelihoods, and reduce global suffering.”

At a Special Session of the World Health Assembly in late 2020, WHO Member States adopted a resolution asking WHO to study the origins of SARS-CoV-2. Accordingly, a joint mission between international and Chinese experts travelled to China in January and February 2021, and published their report in March of that year.

In July 2021, Dr Tedros launched SAGO with two mandates: first, to design a global framework to investigate the origins of emerging and re-emerging pathogens, which it published last year, and second, to apply that framework to evaluate scientific evidence to determine the origins of COVID-19.

The work to understand the origins of SARS-CoV-2 remains unfinished. WHO welcomes any further evidence on the origins of COVID-19, and SAGO remains committed to reviewing any new information should it become available.

Also Read:India reports over 200 XFG COVID-19 cases, Experts call it natural evolution

Powered by WPeMatico